Sun Pharma receives approval to market generic semaglutide in South Africa

Sun Pharmaceutical Industries Limited announced that it has received approval from the South African Health Products Regulatory Authority (SAHPRA) to manufacture and market a generic version of semaglutide

To access the full article, please log in or subscribe.